Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Everolimus”

884 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 884 results

Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60
Post-approval studies (Phase 4)UnknownNCT01239953
What this trial is testing

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)

Who this might be right for
In-Stent Restenosis
Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular 190
Testing effectiveness (Phase 2)UnknownNCT01216839
What this trial is testing

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Who this might be right for
Refractory or Relapsed RMS and Soft Tissue Sarcomas
Sidnei Epelman 20
Early research (Phase 1)Study completedNCT01469572
What this trial is testing

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Who this might be right for
Neuroendocrine Tumors
Emory University 13
Not applicableUnknownNCT04236609
What this trial is testing

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

Who this might be right for
DiabetesCoronary Artery DiseaseAcute Coronary Syndrome
Concept Medical Inc. 3,050
Not applicableStudy completedNCT03730428
What this trial is testing

Everolimus Related Pneumonitis in MBC

Who this might be right for
EverolimusPneumonitis
Fudan University 86
Not applicableUnknownNCT02112981
What this trial is testing

BioMime Vs. Xience Randomised Control Clinical Study

Who this might be right for
Coronary Artery Disease
Meril Life Sciences Pvt. Ltd. 256
Post-approval studies (Phase 4)Study completedNCT00170859
What this trial is testing

Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01500070
What this trial is testing

PREVENT: Promus BTK

Who this might be right for
Peripheral Arterial Disease
Flanders Medical Research Program 70
Testing effectiveness (Phase 2)Ended earlyNCT01042028
What this trial is testing

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 39
Early research (Phase 1)Study completedNCT00622258
What this trial is testing

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)Study completedNCT00510068
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Advanced Neuroendocrine Tumors of Pancreatic Origin
Novartis Pharmaceuticals 410
Testing effectiveness (Phase 2)Study completedNCT02017860
What this trial is testing

Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.

Who this might be right for
Neoplasms
Novartis Pharmaceuticals 4
Early research (Phase 1)Ended earlyNCT00373815
What this trial is testing

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
University Hospital Tuebingen 10
Not applicableNot Yet RecruitingNCT07566091
What this trial is testing

Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

Who this might be right for
Coronary Artery Disease
Jung-min Ahn 2,034
Not applicableStudy completedNCT02513719
What this trial is testing

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Who this might be right for
Ischemic Heart DiseaseAngina PectorisCoronary Artery Disease+2 more
Abbott Medical Devices 312
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Post-approval studies (Phase 4)UnknownNCT01268371
What this trial is testing

Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents

Who this might be right for
Coronary Artery Disease
Ajou University School of Medicine 1,462
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Next Page